LH LABORATORY CRP OF AMER HLDGS

Ownership history in Mayar Capital Ltd.  ·  20 quarters on record

This page tracks every 13F SEC filing in which Mayar Capital Ltd. reported a position in LABORATORY CRP OF AMER HLDGS (LH). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
13.11% (2021 Q3)
Avg. % of fund
6.11%
First filed
2021 Q1
Last filed
2025 Q4
Quarters held
20
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 8,333 0% 2.84% $2.1M $250.25
2025 Q3 UNCHANGED 8,333 0% 3.74% $2.4M $285.58
2025 Q2 ADDED 8,333 +200 +2.5% 4.02% $2.2M $260.48
2025 Q1 REDUCED 8,133 -4,300 -34.6% 3.35% $1.9M $230.27
2024 Q4 REDUCED 12,433 -6,339 -33.8% 3.73% $2.9M $226.24
2024 Q3 REDUCED 18,772 -900 -4.6% 4.08% $4.2M $219.82
2024 Q2 REDUCED 19,672 -447 -2.2% 3.72% $4.0M $199.55
2024 Q1 REDUCED 20,119 -3,027 -13.1% 3.76% $4.4M $213.43
2023 Q4 UNCHANGED 23,146 0% 4.27% $5.3M $221.32
2023 Q3 UNCHANGED 23,146 0% 3.97% $4.7M $195.10
10 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    LH price (monthly, adj. close)
← Back to Mayar Capital Ltd. Holdings